Covington M&A Update: 22 Transactions Over the Past Year

Despite the challenging and dynamic market conditions driven by COVID-19 as well as the volatility of an election year, Covington has continued to execute, completing 22 transactions since the pandemic began. We continue to see strong investor interest (from both private equity and strategic acquirers) throughout the healthcare, technology and business services segments. If you have interest in current market perspectives, or insights into the transactions we’ve completed (noted below) please contact:

Abby Churchill

Artifact - Iodine

Artifact Health merged with Iodine Software

Wellcare - Corbel

WellCare recapitalized by Corbel

Summit Express acquired by Strive Medical

Covington Associates Announces Advisory Role in the Sale of Proven Process Medical Devices to NextPhase Medical Devices

Proven Process acquired by NextPhase

GW Plastics acquired by Nolato

ADS recapitalized by Court Square

Dental Select acquired by Ameritas

Ce3 merged with Catalyst

Azara merged with Hughes & Company

HMC Healthworks acquired by IBH

AllCare Plus Pharmacy acquired by IQVIA

CloudWave recapitalized by Abry Partners

Baril acquired by TEAM Technologies

3Derm acquired by Digital Diagnostics

Renalogic recapitalized by Carrick

PEI acquired by The Partner Companies

Fred Marvin acquired by VSG

ARK recapitalized by Healy, Hunter, Provident

6 Degrees recapitalized by FTV Capital

Grid Dynamics merged with ChaSerg


Covington Associates is an investment banking firm offering advisory services in the areas of M&A, capital raising, and strategic advisory to middle-market companies across the Healthcare, Business Services, Consumer & Industrial, and Technology verticals. Covington’s mission has remained unchanged since its founding in 1991 – provide clients with the highest caliber of senior-level attention and to remain an advice driven and results focused organization. Since its inception, Covington Associates has completed more than 350 transactions globally for both private and publicly traded companies totaling over $20 billion.